BELVIQ XR Trademark

Trademark Overview


On Wednesday, July 15, 2015, a trademark application was filed for BELVIQ XR with the United States Patent and Trademark Office. The USPTO has given the BELVIQ XR trademark a serial number of 86693918. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 16, 2022. This trademark is owned by Arena Pharmaceuticals GmbH. The BELVIQ XR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations to treat or prevent obesity; pharmaceutical preparations for weight management, weight loss and the maintenance of weight loss; Pharmaceutical preparations for the treatment and prevention of diabetes and metabolic disorders; Pharmaceutical preparations for the promotion of smoking cessation; Pharmaceutical preparations for the treatment and prevention of drug and alcohol abuse
belviq xr

General Information


Serial Number86693918
Word MarkBELVIQ XR
Filing DateWednesday, July 15, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 16, 2022
Registration Number4908131
Registration DateTuesday, March 1, 2016
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 15, 2015

Trademark Statements


Description of MarkThe mark consists of the terms "BELVIQ XR" to the right of a diamond design, intersected by a C-shaped curve design and an S-shaped curve design. The letter "X" in the term "XR" has four parallelograms stacked above one another under its bottom left side. The four parallelograms fade in color from the first one to the last one. The word "BELVIQ" and the S-shaped curve design are in red, the diamond design is in blue, and the C-shaped curve design is in white. The term "XR" and the four parallelograms under the "X" are in blue. The white areas in the mark unless identified already are not claimed as a feature of the mark, and are intended to show background or transparent areas only.
Goods and ServicesPharmaceutical preparations to treat or prevent obesity; pharmaceutical preparations for weight management, weight loss and the maintenance of weight loss; Pharmaceutical preparations for the treatment and prevention of diabetes and metabolic disorders; Pharmaceutical preparations for the promotion of smoking cessation; Pharmaceutical preparations for the treatment and prevention of drug and alcohol abuse
Indication of Colors claimedThe color(s) blue, white, and red is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"XR"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEISAI INC.
Party Type31 - New Owner After Registration
Legal Entity Type11 - Company
AddressWOODCLIFF LAKE, NJ 07677

Party NameArena Pharmaceuticals GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH-4800 Zofingen
CH

Party NameArena Pharmaceuticals GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH-4800 Zofingen
CH

Party NameArena Pharmaceuticals GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH-4800 Zofingen
CH

Trademark Events


Event DateEvent Description
Friday, September 16, 2022CANCELLED SEC. 8 (6-YR)
Monday, March 1, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, August 9, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, August 7, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 7, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 1, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, December 15, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 15, 2015PUBLISHED FOR OPPOSITION
Wednesday, November 25, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 9, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 9, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 4, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 4, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 28, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 14, 2015COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Wednesday, October 14, 2015ASSIGNED TO LIE
Wednesday, October 14, 2015NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, October 14, 2015EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, October 14, 2015EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Tuesday, October 6, 2015ASSIGNED TO EXAMINER
Wednesday, July 22, 2015NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, July 21, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 18, 2015NEW APPLICATION ENTERED IN TRAM